Literature DB >> 277908

Structure-function relationships of heparin species.

R D Rosenberg, G Armand, L Lam.   

Abstract

We have fractionated porcine heparin species of low molecular weight, with an average specific anticoagulant activity of 96 units/mg by affinity chromotography. Highly active and relatively inactive preparations of similar size were obtained with specific anticoagulant activities of 360 and 4 units/mg, respectively. The highly active heparin fraction possesses 1.1 additional residues of glucuronic acid and 1.5 fewer residues of N-sulfated glucosamine per molecule compared to the relatively inactive species. This decrease in N-sulfated glucosamine appears to be secondary to a corresponding increase in N-acetylated glucosamine. This form also contains a tetrasaccharide sequence with a N-sulfated glucosamine at its reducing end as well as equivalent amounts of glucuronic acid and iduronic acid. Furthermore, the internal glucosamine residue of this sequence appears to be N-acetylated. Sufficient amounts of this tetrasaccharide sequence are present within the highly active preparation such that each molecule may be endowed with this structure. The relatively inactive product contains a significantly decreased quantity of this tetrasaccharide sequence such that only [unk]20% of these molecules may possess this structure. The mean distance between nonsulfated uronic acid residues of the highly active species is smaller than that separating similar residues of the relatively inactive product. In addition, a larger number of the nonsulfated uronic acid residues of the highly active material appears either to be present in a restricted region of the molecule separated only by glucosamine residues or to be located at penultimate positions within the polysaccharide chain.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 277908      PMCID: PMC392714          DOI: 10.1073/pnas.75.7.3065

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  THE ROLE OF SERINE IN THE LINKAGE OF HEPARIN TO PROTEIN.

Authors:  U LINDAHL; J A CIFONELLI; B LINDAHL; L RODEN
Journal:  J Biol Chem       Date:  1965-07       Impact factor: 5.157

2.  A modified uronic acid carbazole reaction.

Authors:  T BITTER; H M MUIR
Journal:  Anal Biochem       Date:  1962-10       Impact factor: 3.365

3.  A note on the determination of the ester sulphate content of sulphated polysaccharides.

Authors:  K S DODGSON; R G PRICE
Journal:  Biochem J       Date:  1962-07       Impact factor: 3.857

Review 4.  Biologic actions of heparin.

Authors:  R D Rosenberg
Journal:  Semin Hematol       Date:  1977-10       Impact factor: 3.851

5.  A spectrophotometric method for the microdetermination of hexosamines.

Authors:  Z DISCHE; E BORENFREUND
Journal:  J Biol Chem       Date:  1950-06       Impact factor: 5.157

6.  Formation of anhydrosugars in the chemical depolymerization of heparin.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

7.  The distribution of 2-acetamido-2-deoxy-D-glucose residues in mammalian heparins.

Authors:  J A Cifonelli; J King
Journal:  Carbohydr Res       Date:  1972-02       Impact factor: 2.104

8.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

9.  Macromolecular properties and end-group analysis of heparin isolated from bovine liver capsule.

Authors:  L Jansson; S Ogren; U Lindahl
Journal:  Biochem J       Date:  1975-01       Impact factor: 3.857

10.  Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

View more
  30 in total

1.  Clotting for the Clinician: An Overview of Thrombosis and Antithrombotic Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Cell mutants defective in synthesizing a heparan sulfate proteoglycan with regions of defined monosaccharide sequence.

Authors:  A L De Agostini; H K Lau; C Leone; H Youssoufian; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Filter-entrapment enrichment pull-down assay for glycosaminoglycan structural characterization and protein interaction.

Authors:  Yanlei Yu; Fuming Zhang; Gina Renois-Predelus; I Jonathan Amster; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2020-06-10       Impact factor: 9.381

4.  Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printing.

Authors:  Eric Sterner; Sayaka Masuko; Guoyun Li; Lingyun Li; Dixy E Green; Nigel J Otto; Yongmei Xu; Paul L DeAngelis; Jian Liu; Jonathan S Dordick; Robert J Linhardt
Journal:  J Biol Chem       Date:  2014-02-22       Impact factor: 5.157

5.  Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.

Authors:  J C Stiekema; H P Wijnand; T G Van Dinther; H C Moelker; J Dawes; A Vinchenzo; H Toeberich
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

6.  Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.

Authors:  F A Ofosu; G J Modi; M A Blajchman; M R Buchanan; E A Johnson
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

7.  Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.

Authors:  R Machovich; P I Bauer; P Arányi; E Kecskés; K G Büki; I Horváth
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

8.  Poly(L-lysine) has different membrane transport and drug-carrier properties when complexed with heparin.

Authors:  W C Shen; H J Ryser
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

9.  Effect of heparin and a low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits.

Authors:  M Sasaki; C M Herd; C P Page
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

10.  Evaluation of critical groups required for the binding of heparin to antithrombin.

Authors:  D H Atha; A W Stephens; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.